TGF-β Suppresses β-Catenin-Dependent Tolerogenic Activation
                    Program in Dendritic Cells by Vander Lugt, Bryan et al.
TGF-b Suppresses b-Catenin-Dependent Tolerogenic
Activation Program in Dendritic Cells
Bryan Vander Lugt
1, Zachary T. Beck
1, Robert C. Fuhlbrigge
1, Nir Hacohen
2,3, James J. Campbell
1*
.,
Marianne Boes
1,4*
.
1Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, 2Center for Immunology and Inflammatory Diseases,
Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America, 3Broad Institute of Harvard
and MIT, Cambridge, Massachusetts, United States of America, 4Division of Pediatric Immunology, University Medical Center Utrecht, Wilhelmina Children’s Hospital,
Utrecht, The Netherlands
Abstract
The mechanisms that underlie the critical dendritic cell (DC) function in maintainance of peripheral immune tolerance are
incompletely understood, although the b-catenin signaling pathway is critical for this role. The molecular details by which b-
catenin signaling is regulated in DCs are unknown. Mechanical disruption of murine bone marrow-derived DC (BMDC)
clusters activates DCs while maintaining their tolerogenic potential and this activation is associated with b-catenin signaling,
providing a useful model with which to explore tolerance-associated b-catenin signaling in DCs. In this report, we
demonstrate novel molecular features of the signaling events that control DC activation in response to mechanical
stimulation. Non-canonical b-catenin signaling is an essential component of this tolerogenic activation and is modulated by
adhesion molecules, including integrins. This unique b-catenin-dependent signaling pathway is constitutively active at low
levels, suggesting that mechanical stimulation is not necessarily required for induction of this unique activation program.
We additionally find that the immunomodulatory cytokine TGF-b antagonizes b-catenin in DCs, thereby selectively
suppressing signaling associated with tolerogenic DC activation while having no impact on LPS-induced, b-catenin-
independent immunogenic activation. These findings provide new molecular insight into the regulation of a critical
signaling pathway for DC function in peripheral immune tolerance.
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Introduction
In contrast to significant advances made towards understanding
the signals that control dendritic cell (DC) function in activating T
cells during inflammation (immunogenic function), relatively little
is known about the signals that control DC function in suppressing
inappropriate T cell responses during steady state (tolerogenic
function) [1,2]. Manicassamy et al. recently demonstrated that b-
catenin signaling is an important component of tolerogenic DC
function in peripheral immune tolerance [3]. Mice in which b-
catenin signaling is selectively ablated in DCs show striking defects
in DC-mediated Treg homeostasis and disease susceptibility.
Elucidating the mechanisms by which b-catenin signaling is
regulated in DCs may therefore yield insight into the molecular
basis for tolerogenic DC function and provide novel targets for
therapeutic manipulation of antigen-specific immune responses.
Murine bone marrow-derived DCs (BMDCs) respond to a wide
range of stimuli, including sterile mechanical stimulation [4].
Mechanical disruption of cell clusters induces an activation
program. that is distinct from the activation induced by TLR
ligands such as LPS [5]. Whereas DCs activated by TLR ligands
acquire the capacity to stimulate T cell immunity, BMDCs
activated by cluster disruption have immunophenotypic charac-
teristics of mature DCs, yet functionally resemble naı ¨ve DCs in
their ability to promote T cell tolerance. They stimulate T cells to
produce cytokine profiles associated with immune tolerance, and
will protect against autoimmune disease when used to immunize
recipient mice (6). Activation of DCs in this model (hereafter
refered to as tolerogenic activation) is associated with b-catenin
signaling that is distinct from signaling pathways commonly
associated with DC responses to inflammatory stimuli such as
TLR ligands [6]. This model is therefore a useful tool to explore
the association between b-catenin signaling and tolerogenic
activation, as well as to explore how this critical pathway is
regulated in DCs.
The balance between immunity and tolerance is regulated at
many levels, including by cytokine signals. TGF-b is a cytokine
whose signaling is strongly associated with immune suppression
and tolerance [7,8]. TGF-b suppresses DC responses to non-
pathogen-associated stimuli [9], suggesting the possibility that
TGF-b may counteract non-inflammatory b-catenin activation
pathways in DCs. TGF-b signaling is indeed a known regulator of
b-catenin signaling [10]. In this report, we have exploited the
BMDC model in order to explore the role of b-catenin signaling in
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TGF-b influences b-catenin signaling and tolerogenic responses in
DCs.
Methods
Mice
WT C57BL/6 mice were purchased from the Jackson
Laboratories. CD11b
-/- mice were generously provided by T.
Mayadas (Harvard Medical School). Animal studies were
approved by the Brigham and Womens’ Hospital/Harvard
Medical School institutional review and ethics committee
(approval ID of permit number 02726). Mice were maintained
in specific pathogen-free conditions in accordance with institu-
tional guidelines.
Cell culture
Bone marrow-derived dendritic cells were cultured as previously
described [11]. In brief, bone marrow was flushed from the femur
and tibia, RBC were lysed, and the remaining cells were cultured
at 10
6 cells/ml in RPMI medium with 10 ng/ml murine GM-CSF
(Peprotech) and various concentrations of CHO-derived human
TGF-b1 (Peprotech). Media was refreshed every other day.
Cell stimulation and flow cytometry
Inflammatory stimulation: Day 5 BMDCs were stimulated for
24 hours with 100 ng/ml LPS (Sigma-Aldrich). Tolerogenic
stimulation: loosely adherent day 5 BMDCs were collected by
repeated pipetting and resuspended in fresh media for 24 hours. In
some cases, CD11c magnetic beads (Miltenyi Biotec) were used
according to manufacturer’s instructions to simultaneously purify
CD11c+ cells and introduce mechanical stimulation. Integrin-
mediated stimulation: LEAF-purified antibodies (Biolegend) were
added to cultured cells to 1.5 mg/ml final concentration for 24
hours. Following stimulation, loosely adherent cells were collected
by pipetting, for analysis by flow cytometry.
Calculation of Induced Maturation
To calculate the impact of TGF-b on DC responsiveness to
stimulation required that we first correct for the effect of TGF-b on
unstimulated levels of spontaneously mature DCs. Percent induced
maturation is therefore the percentage of MHC-II
hi/CD86
+/
CCR7
+ DCs in the stimulated condition after subtracting the
percentage in the unstimulated condition. Fold-induced maturation
is calculated as the ratio of induced maturation in the experimental
group to the induced maturation in the control group.
Lentiviral shRNA infection
pLKO vector-encoded lentivirus was produced as previously
described [12]. BMDCs were cultured for 2 days with TGF-b
before spin infection with 8 ug/ml polybrene at 2 MOI. Medium
was replaced at day 4 with fresh medium containing 1 mM TGF-b
Receptor Kinase Inhibitor (TRI) (Calbiochem) and 5 uM
puromycin (Sigma). For stimulation studies, cells were stimulated
2 days following selection and analyzed 24 hours after stimulation.
Western blots
Immunoprecipitations were completed using anti-E-Cadherin
(DECMA, Abcam) with lysates prepared from CD11c-purified
BMDCs using the Pierce Classic IP Kit according to manufactur-
er’s instructions. Protein fractions were run on 4–20% polyacryl-
amide gels (Biorad) and transferred to PVFD membranes. After
blocking, membranes were stained either with unconjugated whole
rabbit anti-serum against b-catenin (Sigma) or unconjugated anti-
tubulin (Cell Signaling). HRP-conjugated goat anti-rabbit (Cell
Signaling) was used as a secondary stain.
Reporter Assays
Day 2 control or TGF-b BMDCs were infected with lentiviral
reporter constructs (Cignal, SABiosciences) following the protocol
outlined above with MOI 2. Infected cells were maintained in
control or TGF-b medium until analysis on D5. BMDC lysates
were prepared and analyzed using a luciferase assay kit (Agilent
Technologies) according to manufacturers instructions.
Epifluorescence Microscopy
BMDCs were cultured for 5 days. CD11c+ cells were purified
by magnetic beads (Miltenyi) and plated onto glass coverslips. Cells
were allowed to adhere for 24 hours before fixation with 4%
paraformaldehyde. Cells were then permeabilized and stained
with antibodies or phalloidin (actin), were washed, and mounted
with DAPI-containing medium (Invitrogen).
Results
BMDCs Recapitulate Tolerogenic versus Imunogenic DC
Function
We cultured immature bone marrow-derived dendritic cells
(BMDCs) to study mechanisms that may orchestrate tolerogenic
DC maturation. We began our studies by reproducing aspects of
this model reported previously (Figure 1). DC maturation
encompasses many changes in protein expression and function,
including alterations in the transcript levels of hundreds of genes,
with different stimuli resulting in different patterns of transcrip-
tional responses [13]. As current nomenclature is inadequate to
describe variable DC activation states, for the purposes of this
report we will define a mature DC as an activated cell that displays
enhanced antigen presentation capability. At a minimum, this
requires increased surface display of MHCII-peptide complexes
and costimulatory molecules (i.e. CD86), as well as expression of
the chemokine receptor CCR7 that allows migrating DCs to reach
tissue-draining lymph nodes and interact with T cells therein. For
simplicity, we will therefore define a mature DC as one expressing
high levels of these three molecules.
As defined by our criteria, a relatively small percentage of
BMDCs underwent spontaneous maturation without manipula-
tion (identified by the MHCII/CD86/CCR7
hi immunopheno-
type) (Figure 1A). We find that levels of spontaneous maturation
range from 5–20% in our hands. However, maturation was
dramatically increased above spontaneous levels upon exposure to
inflammatory stimulation (i.e., LPS). As previously reported, we
also find that maturation is robustly induced by mechanical
disruption of BMDC clusters (i.e. stimulation by mechanical
agitation). We confirmed by flow cytometry that both types of
maturation stimuli activated the ‘‘core’’ aspects of the DC
maturation response (Figure 1A).
BMDCs induced to mature by exposure to LPS are reported to
orchestrate immunogenic T cell responses, while those matured by
mechanical stimulation can coordinate tolerogenic responses [6].
We confirmed this important distinction with a functional test
similar to that first described with this model [6]. We stimulated
BMDC cultures either with LPS or with mechanical stimulation,
pulsed the activated DCs with antigen, and used the DCs to
immunize recipient mice. After 3 immunizations we harvested
spleens from recipient mice (using spleens from mice that had
received no immunizations as controls) and challenged splenocytes
ex vivo with cognate antigen. We find that while both LPS- and
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well (as measured by
3H-thymidine uptake and IL-2 production
[Figure 1B]), the cytokine profile elicited by mechanically-
stimulated BMDCs (high IL-10, low IFN-c, low IL-17) was
distinct from that induced by LPS-stimulated BMDCs and
consistent with immune tolerance (Figure 1C).
Figure 1. BMDCs Recapitulate Tolerogenic vs Immunogenic DC Function. (A) BMDCs were cultured for 5 days and either left unstimulated
(spontaneous maturation, upper left panel), treated with LPS (upper middle panel), or stimulated by mechanical agitation (upper right panel). Twenty four
hours after stimulation, BMDCs were collected and analyzed by flow cytometry for maturation status. Mature (Mat) BMDCs were identified as
CD11c
+MHCII
hiCD86
hiCCR7
hi.I m m a t u r e( I m m )a r eC D 1 1 c
+MHCII
intCD86
-CCR7
-. (B,C) Day 5 BMDCs were purified/mechanically-stimulated with CD11c
magnetic beads and replated with 100 ng/ml LPS (Mech+LPS) or without (Mech). Stimulated cells were pulsed for 2 hours with chicken ovalbumin
peptide OVA 323–339 (10 mg/ml)andwashedbefore injection i.v. intorecipientmice.Recipient mice receivedtreatedDCinjections ondays 0,2,and4.On
day 7,splenocytesfrom recipient mice andcontrol mice thathadreceivednoinjections (Cont)wereharvestedandrechallenged exvivowithOVA peptide
for 72 hours. (B) Proliferation was measured either by adding H
3Thy during the final 18 hours of challenge or by ELISA for IL-2 levels in the culture
supernatant. (C) Cytokine levels in culture supernatant associated with tolerance (IL-10) and immunity (IFNc and IL-17) were determined by ELISA.
*p,0.05.FACSplotsinpartAaresingleexperimentsrepresentativeofmorethan3repeats.GraphsinB,Cshowdatafrom3experimentsasmean+/2SEM.
doi:10.1371/journal.pone.0020099.g001
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Response to Mechanical Signals
As an initial step to understanding tolerogenic function in
BMDCs, we sought to better understand the molecular mecha-
nisms by which mechanical stimulation induces maturation.
Previous studies with mechanical stimulation have utilized
relatively poorly defined stimuli to introduce mechanical stimula-
tion, such as simple pipetting [4] or purification with magnetic
beads [6], which has hampered the ability to precisely identify the
molecular mechanisms that mediate the ensuing response. It has
been proposed that mechanical disruption of homotypic E-
Cadherin interactions between adjacent BMDCs initiates b-
catenin signaling and the tolerogenic response [6]. We found,
however, that individual BMDCs can respond to mechanical
signals independently of the disruption of cell-cell interactions
(Figure S1). Therefore, BMDCs appear intrinsically capable of
responding to mechanical signals. This finding implicates the
involvement of alternative molecules in addition to E-Cadherin in
the response to mechanical stimulation.
In addition to cadherins, integrins also make important contribu-
tions to cellular responses to mechanical signals [14,15]. DCs express
high levels of b2 integrins, including CD11b (aM) and the DC
lineage-associated CD11c (aX). We reasoned that if integrins are
involved in initiating signaling events in response to mechanical
stimulation, it might be possible to mimic mechanical stimulation
with a defined stimulus against BMDC integrins. This approach also
has the desirable advantage of circumventing the poorly defined
stimulus of repeated pipetting to introduce mechanical signals. To
determine whether direct stimulation of integrins initiates maturation
similar to that induced by mechanical agitation, we stimulated
BMDC cultures with an antibody to CD11b. We found that integrins
can indeed initiate maturation, albeit to slightly lower levels than that
observed with mechanical stimulation (Figure 2A). This response to
CD11b MAb was dependent on the presence of CD11b, as
evidenced by the absence of a similar response from CD11b
-/-
BMDCs (Figure 2A). However, the BMDC response to mechanical
stimulation did not require the participation of CD11b under our
standard conditions, as it occurred normally in cells from CD11b
-/-
mice (Figure 2A). We conclude that although integrins such as
CD11b can facilitate DC maturation consistent with mechanical
agitation, the tolerogenic response to mechanical stimulation is not
uniquely dependent on a single integrin.
Interestingly, we found that the ability of anti-CD11b antibodies
to initiate integrin-mediated activation varied by clone. While
clones M170 and 5C6 bind with equal efficiency to CD11b (Figure
S2), clone M170 induced maturation but clone 5C6 did not
(Figure 2A). This suggests that integrin crosslinking alone is not
sufficient to initiate maturation signals. The binding sites for these
two antibodies have not been mapped, but are evidently not in
close enough proximity to block each other’s binding (Figure S2).
We propose that the antibody-induced stimulatory effect on DCs
depends upon the MAb’s ability either to stabilize or force an
activated integrin conformation. We also observe that the addition
of the M170 clone (but not other clones) to cultured BMDCs
results in the CD11b-dependent formation of large clusters of cells
within 1 hour, further suggesting that disruption of cells clusters is
not a critical component of the response to mechanical signals
(BJV, data not shown).
Figure 2. Tolerogenic Response to Mechanical Stimulation is Controlled by a Distinct Signaling Pathway. (A) Day 5 WT or CD11b
-/-
BMDCs were stimulated with 100 ng/ml LPS, with mechanical agitation, or by adding 1.5 ug/ml anti-CD11b (clones M170 or 5C6) to culture medium.
24 hours later maturation status was assessed by flow cytometry as in Fig 1. To correct for TGF-b-mediated differences in levels of spontaneous
maturation, we calculate percent ‘‘induced maturation’’ as described in the methods section. The percentage of spontaneously mature DCs was
comparable between WT and CD11b
-/-.DCs Data from 3 experiments is summarized as mean 6 SEM. N.D. Not Detected. (B) BMDCs were infected
with 2 independent lentiviral shRNA clones against b-catenin, or with control shRNA against luciferase. Cell extracts were prepared 6 days after
infection and knockdown efficiency was confirmed by western blot. Blots are representative of 3 experiments. (C) BMDCs were infected as in (B).
Infected BMDCs were stimulated with LPS, mechanical agitation, or by integrin stimulation (aCD11b clone M170) and analyzed 24 hours later by flow
cytometry. Data from 3 experiments is summarized as mean +/- SEM.
doi:10.1371/journal.pone.0020099.g002
b-Catenin Signaling in Tolerogenic Dendritic Cells
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e20099b-catenin Signaling is Necessary for Tolerogenic
Mechanical Response and Spontaneous Maturation
b-catenin signaling is an important component of tolerogenic
DC function in vivo. Consistent with this observation, mechanical
stimulation, which activates DCs while preserving their tolerogenic
potential, is known to induce b-catenin signaling in BMDCs.
Experimentally-induced b-catenin signaling is sufficient to promote
DC maturation [6]; however, it remains unclear whether b-
catenin signaling is necessary for the generation of tolerogenic DCs
by mechanical stimulation.
To determine whether mechanical stimulation and/or integrin-
mediated activation require b-catenin-mediated signals, we used a
lentivirus shRNA knockdown approach to reduce the availability of
functional b-catenin. We characterized two independent shRNA
clones against b-catenin, each producing a substantial reduction of
total b-catenin protein (Figure 2B). BMDCs infected with these
shRNAs developed normally, expressed normal levels of CD11c, and
remained viable (as measured by scatter profile, Figure S3). While b-
catenin-depleted BMDCs responded normally to LPS stimulation,
they did not respond to mechanical or integrin-mediated stimulation
(Figure 2C). This demonstrates that b-catenin signaling is a necessary
component of the activation program induced by mechanical signals.
b-catenin signaling is constitutively active in steady state
tolerogenic DCs in vivo, though it remains unclear whether this
activation is initiated by canonical Wnt signals or via alternative
means [3]. We therefore investigated whether b-catenin-depen-
dent signals are constitutively active in BMDCs and whether these
signals regulate the observed spontaneous BMDC maturation, as
they regulate DC maturation induced by mechanical stimulation.
To this end, we first cultured BMDCs on low adherence tissue
culture surfaces to reduce interactions between cell adhesion
molecules and the culture substrate. Although ‘‘immature’’
CD11c
+ DCs developed normally from BM precursors under
these conditions, spontaneous maturation (as measured by
upregulation of MHCII and CD86) was reduced with respect to
maturation achieved on standard culture substrates (Figure 3A).
We next infected BMDCs with shRNA lentiviruses targeting b-
catenin as above, and then cultured the infected cells for an
additional 7 days. Although we observe lower levels of spontane-
ous maturation with our infection protocols (compare leftmost
panels of Figure 3A with Figure 3B), we repeatedly observed
approximately 80% reduction in the levels of spontaneous
maturation in b-catenin-depleted DCs in comparison to control-
infected cells (Figure 3B). We conclude that b-catenin-mediated
Figure 3. Signals Associated with Tolerogenic Function are Constitutively Active. (A) BMDCs were cultured for 5 days on standard tissue
culture treated plates or on low adherence plates (hydrogel-coated, Invitrogen) and then analyzed for maturation status by flow cytometry. Gates are
drawn on CD11c
+MHCII
hi/CD86
hi mature cells. (B) BMDCs were infected with luciferase or b-catenin shRNA as in Fig 2 and cultured for 7 days post-
infection before maturation status was assessed by flow cytometry. Mature cells are identified as in (A). Numbers indicate percent within mature gate.
Data from parts A&B are representative of at least 3 repeats.
doi:10.1371/journal.pone.0020099.g003
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spontaneous maturation.
TGF-b Selectively Suppresses Spontaneous and
Mechanically-stimulated DC Maturation
TGF-b is a critical regulator both of immune tolerance and of
DC biology. TGF-b is also a known regulator of b-catenin
signaling. We therefore considered the notion that TGF-b may
regulate b-catenin-dependent signaling in DCs. To assess the
impact of TGF-b on BMDC maturation, we first cultured BMDCs
with titrated concentrations of TGF-b. We found that increasing
TGF-b doses correlated inversely with the appearance of
spontaneously matured BMDCs (Figure 4A). To determine
whether TGF-b rendered BMDCs terminally incapable of
maturation, we exposed TGF-b-cultured DCs to either LPS or
mechanical stimulation. TGF-b-treated DCs responded robustly
to LPS stimulation, indicating that the general maturation
program was intact. In contrast, mechanically-stimulated matura-
tion was dramatically inhibited (Figure 4B).
Although LPS-responsive CD11c
+ ‘‘immature’’ DCs expand
from BM at normal rates in the presence of TGF-b (Figure 4B), we
considered the possibility that these cells might have been
functionally altered with respect to immature DCs that were
never exposed to TGF-b. The observed suppression of maturation
might be a direct, reversible effect of TGF-b; or an indirect effect
resulting from induction of an alternative developmental pathway.
To distinguish between these two possibilities, we performed the
initial BMDC culture in the absence of exogenous TGF-b, but
then added TGF-b for a 24 h period prior to mechanical or LPS
stimulation. Under these conditions, TGF-b again suppressed
mechanically-stimulated maturation in a dose-dependent manner
(Figure 4C), but did not effect LPS-induced maturation at any of
the concentrations tested (Figure 4D). These data favor the
conclusion that exogenous TGF-b exerts a direct suppressive effect
on mechanically-stimulated DC maturation.
TGF-b Alters BMDC Morphology
Selective suppression of mechanically-stimulated DC matu-
ration by TGF-b indicates that activation by this stimulus is
uniquely dependent on a TGF-b-sensitive signaling molecule.
We first investigated the impact of TGF-b on DC morphology
during culture. We found no effect of TGF-b on BMDC cluster
formation (Figure 5A). However, individual cells that were not
congregated in cell clusters were noticeably altered in
morphology. Without TGF-b, many of these cells displayed a
‘‘spread’’ conformation on the tissue culture surface (Figure 5A,
arrows). Cytoskeletal activation is associated with DC matura-
tion [16], so these ‘‘spread’’ cells are likely to comprise the
spontaneously matured BMDC population observed by flow
cytometry (as seen in Figure 1A). Such ‘‘spread’’ cells were not
evident in TGF-b-treated DC cultures, where cells that were
not congregated in clusters remained comparatively round
(Figure 5A). The relative absence of spread cells might simply
reflect the observed TGF-b-mediated reduction in spontaneous
DC maturation (as seen in Figure 4A). More interestingly
however, the decreased cell spreading might instead result from
ad i r e c te f f e c to fT G F - b on DC cytoskeletal organization or
adhesion.
Figure 4. TGF-b Selectively Suppresses Spontaneous and Mechanically-stimulated Maturation. (A) BMDCs were cultured for 5 days in the
presence of the indicated TGF-b concentration before analysis for maturation status by flow cytometry as in Fig 1. Graphs indicate levels of
spontaneous maturation relative to control cultures. (B) BMDCs cultured in the presence of TGF-b for 5 days were stimulated with either LPS or
mechanical agitation before analysis by flow cytometry. Gates are drawn for the CD11c
+MHCII
hi mature (Mat) population. (C) Day 4 control BMDCs
were exposed for 24 hours to the indicated concentration of TGF-b, then cells were stimulated by mechanical agitation. After another 24 hours,
stimulated cells were collected and analyzed for maturation status by flow cytometry. (D) Cells were cultured as in (C) with TGF-b added to 10 ng/ml.
Twenty four hours after the addition of TGF-b, cells were stimulated with the indicated concentration of LPS. After another 24 hours, cells were
collected and analyzed for maturation status by flow cytometry. Panels in B are representative examples of at least 3 repeats. Graphs in A,C&D depict
the mean+/2 SEM of 3 experiments.
doi:10.1371/journal.pone.0020099.g004
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purify CD11c
+ cells from TGF-b
+ or TGF-b
- BMDC cultures, a
process that in itself provides mechanical stimulation [6]. By
purifying DC we were also able to confirm that our observations in
heterogeneous BMDC cultures were specific to DCs rather than
residual macrophages. We re-plated DCs in the presence or
absence of LPS for 24 h, and analyzed them for morphological
changes by microscopy. We found that TGF-b-treated BMDCs
did not spread on the culture surface, regardless of the presence or
absence of LPS (Figure 5B). As seen for experiments described
above (Figure 4B), the ability of LPS to stimulate core maturation
was not inhibited by TGF-b. Thus, TGF-b appears to directly
alter DC morphology independently of LPS-inducible ‘‘core’’
maturation.
TGF-b Disrupts b-catenin Signaling.
Three observations suggested to us that in addition to the
disruption of the cytoskeleton and adhesion molecules, TGF-b
additionally disrupts downstream b-catenin signaling. First,
although TGF-b reduced the surface levels of CD11b, a
substantial amount did remain (Figure S2), yet was not capable
of transmitting maturation signals (Figure 2). Second, we noted
that b-catenin-depleted BMDCs exhibited a rounded morphology
when compared with control infected BMDCs (Figure 6A),
consistent with our observations of TGF-b-treated BMDCs
(Figure 5B). Third, while treatment of control BMDCs with LiCl
(a potent inducer of b-catenin signaling [17]) resulted in
maturation, TGF-b-treated BMDCs failed to respond to LiCl
(Figure 6B). We therefore reasoned that b-catenin might comprise
a direct target of TGF-b-mediated inhibition.
To address this possibility, we examined the effects of TGF-b on
b-catenin function. Given the morphological changes we observed
after TGF-b treatment, we first examined the structural function
of b-catenin. To investigate the possibility that TGF-b disrupts b-
catenin/E-Cadherin associations, we immunoprecipitated (IP) E-
Cadherin from TGF-b-cultured DC lysates. Western blots
demonstrate that TGF-b did not inhibit co-precipitation of b-
catenin with E-Cadherin, suggesting that this particular associa-
tion is not disrupted (Figure 6C). Interestingly, we found that the
amount of b-catenin not associated with E-Cadherin was increased
in TGF-b-treated cells (Figure 6C).
In addition to its structural role, b-catenin serves as a
transcription factor. To evaluate the impact of TGF-b on b-catenin
transcriptional activity, we infected BMDCs with a lentiviral TCF/
LEF-luciferasereporter.Wefoundthat TGF-b suppresses b-catenin
transcriptional activity (Figure 6E). Thus, we demonstrate that
TGF-b directly regulates b-catenin signaling in DCs, thereby
suppressing a critical component required for initiating the unique
tolerogenic activation program by mechanical stimulation.
Discussion
We set out to better define the molecular mechanisms by which
mechanical stimulation induces the unique tolerogenic activation
program in BMDCs and to investigate the function and regulation
of b-catenin signaling in this response. By this approach, we
describe several novel features of b-catenin signaling in DCs.
Although it has been proposed that disruption of E-Cadherin-
mediated cell-cell initiates the tolerogenic program [6], we find
that individual BMDCs respond to mechanical stimulation in the
absence of cell-cell contacts and that additional adhesion
molecules, including integrins, may play an important role in
regulating DC activation. We further demonstrate that activated
b-catenin is not only sufficient to promote BMDC maturation, it is
indeed a necessary component for tolerogenic DC activation by
mechanical stimulation. By contrast, LPS-induced immunogenic
maturation is independent of b-catenin. Finally, we demonstrate
that TGF-b disrupts b-catenin signaling, thereby selectively
suppressing this response while leaving immunogenic activation
undisturbed.
b-catenin signaling is constitutively active in tolerogenic DC
subsets in vivo [3], yet the signal that initiates b-catenin signaling in
steady state DCs is unknown. Although peripheral tissues like the
skin are subject to mechanical agitation, evidence has been lacking
as to whether such stimulation may itself be required for steady
state DC function [18]. Wnt ligands are expressed by DCs in vivo
suggesting the possibility of autocrine activation in the absence of
external signals [3]. Therefore, it is noteworthy that in the BMDC
model, b-catenin-dependent maturation will occur spontaneously
in the absence of any exogenous stimulus. We find, however, that
adhesive interactions between DCs and the tissue culture surface
modulate the extent of spontaneous maturation, indicating that
non-canonical signals contribute to the regulation of the b-catenin
Figure 5. TGF-b Directly Alters DC Morphology. (A) Day 5 BMDCs
cultured in the presence or absence of TGF-b were visualized for both
cell cluster formation and cell morphology by microscopy. Arrows
indicate cells that have spread onto the tissue culture surface. These
cells are not apparent in TGF-b cultures. (B) CD11c+ cells cultured as in
(A) were purified/mechanically-stimulated with magnetic beads and re-
plated in medium with or without 100 ng/ml LPS. Twenty four hours
after stimulation cells were analyzed by microscopy. Note the
cytoskeletal activation and cell spreading in control DCs that is absent
in TGF-b DCs, even when stimulated by LPS. White arrows in upper
panels indicate punctate actin staining. All images are representative of
at least 3 independent experiments.
doi:10.1371/journal.pone.0020099.g005
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we propose that b-catenin-depdendent tolerogenic DC function in
vivo may not be driven by mechanical stimulation per se, but rather
by a constitutively or stochastically active signal modulated by
adhesion molecules and intensified by mechanical stimulation.
Further studies will be required to determine the contributions of
canonical wnt signaling and alternative signaling mediated by
adhesion molecules to steady state tolerogenic DC function in vivo.
Our data provide insight into mechanisms that may regulate
signaling pathways associated with tolerogenic DC function in vivo.
TGF-b is a well-established regulator of DC development,
chemoattraction and function, particularly for DC subsets in
peripheral tissues such as skin, the lungs, and the gut [8,19,20,21].
As TGF-b is strongly associated with immune suppression, it is
perhaps counterintuitive that TGF’b antagonizes a signaling
pathway associated with tolerogenic DC function. However,
peripheral tissues are continuously subject to mechanical stress
that would be predicted to initiate wide-spread activation of DCs.
We speculate that TGF-b may act directly to suppress DC
activation by opposing b-catenin-dependent signaling. Consistent
with this model, mice in which DCs are deficient in TGF-b
signaling display enhanced spontaneous DC maturation and
migration [22]. It is noteworthy that even at the highest
concentrations of TGF-b tested in our in vitro model, we continued
to observe low levels of spontaneous maturation. Therefore, even
in a TGF-b-rich environment our model predicts infrequent but
measurable maturation to occur, consistent with in vivo observa-
tions [23]. As immunogenic activation signaling pathways are not
sensitive to TGF-b suppression, robust maturation is predicted
upon DC exposure to inflammatory signals. It is also important to
note that TGF-b suppresses an activation program that preserves
the tolerogenic function found in unstimulated DCs, but would not
be expected to inhibit tolerogenic function per se.
The unique role of b-catenin in tolerogenic DC function, and
the finding that this molecule may be regulated independently of
immunogenic DC signaling, is particularly intriguing with respect
to therapeutic manipulation of antigen-specific immune responses.
It suggests that signaling pathway components uniquely associated
with immunogenic or tolerogenic DC function in vivo might be
selectively targeted, in order that one might ‘‘steer’’ DC function
towards a desired functional outcome and thereby shift the
balance of immunity and tolerance in human disease. Further
research will be required to explore the validity of this concept.
Supporting Information
Figure S1 Disruption of cell-cell contacts is not essential
for BMDC response to mechanical stimulation. Day 5
CD11c
+ BMDCs were purified by magnetic bead separation
(Miltenyi). TGF-b was included in initial culture to prevent
maturation during purification. Purified DCs were replated at
sufficiently low density to minimize cell-cell contact formation. 24
Figure 6. TGF-b Disrupts b-catenin Function. (A) BMDCs were infected with either control or b-catenin shRNA as in Fig 2. shRNA infected cells
were analyzed by microscopy 6 days after infection. Images are representative of 3 experiments. (B) BMDCs were cultured for 5 days with or without
TGF-b, then stimulated with 10 mM LiCl. 24 hours after stimulation, maturation was assessed by flow cytometry as in Fig 1. Graphs display data from
3 experiments as mean6SEM. (C) BMDCs were cultured for 5 days in the presence (+TGF-b) or absence (Cont) of TGF-b. CD11c
+ cells were purified on
ice with magnetic beads and lysed immediately to avoid mechanical maturation induced changes. E-Cadherin (E-Cad) was immunoprecipitated from
lysates and both precipitate and E-Cad depleted fractions were analyzed for b-catenin by western blot. Blots are representative of 2 experiments. (D)
Day 2 BMDCs cultured with (+TGF-b) or without (Cont) TGF-b were infected with TCF/LEF lentiviral luciferase reporters. On Day 5, cell lysates were
prepared from infected cells, luciferase substrate was added to lysates, and the resulting luminescence was measured. Graph shows data from 3
experiments as mean+/2 SEM.
doi:10.1371/journal.pone.0020099.g006
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PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e20099hours after replating, DCs were either left untreated or
mechanically-stimulated by repeated pipetting and replated. 48
hours after initial purification, DCs were assessed for maturation
by flow cytometry. Plots are representative of 3 experiments.
(TIF)
Figure S2 Integrins and DC activation. A) CD11b
expression on Day 5 BMDCs was assessed by flow cytometry
using either the M170 or 5C6 clones. Grey indicates isotype
control staining. Both clones show similar levels of binding. B)
BMDCs were either left untreated (Cont) or pretreated with
unconjugated 5C6 before staining with PE-conjugated M170.
Pretreatment with 5C6 did not block M170 binding. C) CD11a
and CD11b expression levels were analyzed by flow cytometry on
Day 5 conventional (Cont) or TGF-b-cultured BMDCs.
(TIF)
Figure S3 Lentiviral shRNA knockdowns in BMDCs. A)
shRNA-infected BMDCs display normal flow cytometry scatter
profile after puromycin selection. B) BMDCs infected with control
shRNA were analyzed for maturation before and after stimulation
by flow cytometry. Stimulated DCs display over 20-fold increase in
levels of DCs bearing markers of maturation after stimulation.
(TIF)
Acknowledgments
We thank members of the Harvard Skin Disease Research Center for
helpful discussions and comments. From the Hacohen lab, we thank Weibo
Li for lentivirus production and Rebecca McDonald for BMDC infection
protocols.
Author Contributions
Conceived and designed the experiments: BVL ZTB RCF NH JJC MB.
Performed the experiments: BVL ZTB. Analyzed the data: BVL ZTB
RCF NH JJC MB. Contributed reagents/materials/analysis tools: NH JJC
MB. Wrote the paper: BVL JJC MB.
References
1. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells.
Annu Rev Immunol 21: 685–711.
2. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic
cells: which signals induce tolerance or immunity? Trends Immunol 23:
445–449.
3. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, et al.
(2010) Activation of beta-catenin in dendritic cells regulates immunity versus
tolerance in the intestine. Science 329: 849–853.
4. Gallucci S, Lolkema M, Matzinger P (1999) Natural adjuvants: endogenous
activators of dendritic cells. Nat Med 5: 1249–1255.
5. Fu C, Jiang A (2010) Generation of tolerogenic dendritic cells via the E-
cadherin/beta-catenin-signaling pathway. Immunol Res 46: 72–78.
6. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, et al. (2007) Disruption of E-
cadherin-mediated adhesion induces a functionally distinct pathway of dendritic
cell maturation. Immunity 27: 610–624.
7. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted
disruption of the mouse transforming growth factor-beta 1 gene results in
multifocal inflammatory disease. Nature 359: 693–699.
8. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming
growth factor-beta regulation of immune responses. Annu Rev Immunol 24:
99–146.
9. Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, et al. (1999) TGF-beta
1 prevents the noncognate maturation of human dendritic Langerhans cells.
J Immunol 162: 4567–4575.
10. Letamendia A, Labbe E, Attisano L (2001) Transcriptional regulation by Smads:
crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 83-A
Suppl 1: S31–39.
11. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of
large numbers of dendritic cells from mouse bone marrow cultures supplement-
ed with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:
1693–1702.
12. Amit I, Garber M, Chevrier N, Leite AP, Donner Y, et al. (2009) Unbiased
reconstruction of a mammalian transcriptional network mediating pathogen
responses. Science 326: 257–263.
13. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, et al. (2001) The plasticity
of dendritic cell responses to pathogens and their components. Science 294:
870–875.
14. Jamora C, Fuchs E (2002) Intercellular adhesion, signalling and the cytoskeleton.
Nat Cell Biol 4: E101–108.
15. Schwartz MA, DeSimone DW (2008) Cell adhesion receptors in mechan-
otransduction. Curr Opin Cell Biol 20: 551–556.
16. Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, et al. (2004) Maturation of
DC is associated with changes in motile characteristics and adherence. Cell
Motil Cytoskeleton 57: 118–132.
17. Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase
kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:
1664–1668.
18. van den Broek M (2007) Dendritic cells break bonds to tolerize. Immunity 27:
544–546.
19. Borkowski TA, Letterio JJ, Farr AG, Udey MC (1996) A role for endogenous
transforming growth factor beta 1 in Langerhans cell biology: the skin of
transforming growth factor beta 1 null mice is devoid of epidermal Langerhans
cells. J Exp Med 184: 2417–2422.
20. Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M (2009) Intestinal
epithelial cells promote colitis-protective regulatory T-cell differentiation
through dendritic cell conditioning. Mucosal Immunol 2: 340–350.
21. Sato K, Kawasaki H, Nagayama H, Enomoto M, Morimoto C, et al. (2000)
TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood
monocyte-derived dendritic cells via chemokine receptors. J Immunol 164:
2285–2295.
22. Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE (2010) TGF-beta is required
to maintain the pool of immature Langerhans cells in the epidermis. J Immunol
185: 3248–3255.
23. Jakubzick C, Bogunovic M, Bonito AJ, Kuan EL, Merad M, et al. (2008)
Lymph-migrating, tissue-derived dendritic cells are minor constituents within
steady-state lymph nodes. J Exp Med 205: 2839–2850.
b-Catenin Signaling in Tolerogenic Dendritic Cells
PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e20099